© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Resistance to four HIV drug classes is tied to high risk of disease and death.
The antiretroviral drug class includes bictegravir, dolutegravir, elvitegravir and raltegravir.
A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.
This may reflect loss of the weight-suppressing effect of the older version of the drug.
Aging with HIV won’t slow down Robert Gillum.
HIV advocate Lepena Reid confronts weight gain.
Some HIV meds are linked to weight gain, but we don’t yet know why.
Researchers are surprised and concerned that a strain of HIV that is so broadly resistant to treatment even has the capacity to transmit.
Researchers looked at potential drug-drug interactions among Swiss people with HIV and compared them with a cohort from 2008.
People who switched from tenofovir disoproxil fumarate to tenofovir alafenamide gained weight regardless of other meds.
The agency has also lowered the weight threshold for film-coated tablets of the integrase inhibitor.
A rundown of POZ’s reporting on the 2020 Conference on Retroviruses and Opportunistic Infections
Studies have found that weight gain is common after people with HIV begin an antiretroviral in this class.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
